Takeda expands India portfolio of rare disease therapies EP News Bureau Nov 25, 2019 Company launches enzyme replacement therapy bouquet for Lysosomal Storage Disorders (LSD), Idursulfase for Hunter Syndrome,…
Takeda’s dengue vaccine candidate demonstrates protection in children aged four to 16 years,… EP News Bureau Nov 8, 2019 Takeda’s dengue vaccine candidate was generally well-tolerated, and no important safety risks have been observed to date
Stada buys Takeda drug bundle to boost Russia business Reuters Nov 6, 2019 The portfolio, which Takeda is selling in a push to slash debt after its $59 billion purchase of Shire, includes drugs sold…
